Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 254 clinical trials
None

  • None views
None

  • None views
Telitacicept in Primary APS Patients

Telitacicept will be added on traditional antithrombotic and immunosuppressive treatment in primary antiphospholipid syndrome (APS) patients with three positive antiphospholipid antibodies (aPL) and at least one extra-criteria manifestations, including thrombocytopenia, autoimmune hemolytic anemia, aPL associated nephropathy, heart valvular disease, non-stroke neurological manifestations.

  • 0 views
  • 15 Oct, 2021
  • 1 location
Rheumatology Patient Registry and Biorepository

To facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.

polymyositis
rheumatism
dermatomyositis
mixed connective tissue disease
skin conditions
  • 0 views
  • 05 Aug, 2020